Cancer Risk and Disparities

项目总结（见说明）： 癌症风险和差异计划的使命是支持将导致减少癌症风险和社会差异的研究。为实现这一目标，该方案有以下四个具体目标： 1.了解个人，社会心理，组织和社区层面的因素，这些因素决定了整个生命过程和人群中癌症风险的差异。 2.制定、测试和评估干预措施，以降低整个生命过程和人群的癌症风险。 3.推进传播和知识转化科学，促进循证干预措施的传播，以降低癌症风险。 4.检查癌症风险和发病率差异的原因，并确定干预措施以纠正这些差异。 该计划最初于2000年获得资助，当时Dana-Farber/哈佛癌症中心作为一个联盟中心成立，并在2005年最后一次更新时获得了"优秀到杰出"的成绩。该项目由L. Frazier（DFCI）.有两个领导人：K。Viswanath（DFCI）和D.威廉姆斯（HSPH）。在本项目期间，该计划的目标进行了大幅修订，以包括新的研究重点，包括：1）易患癌症风险的个人和社会因素，2）传播科学和3）明确关注癌症差异，所有这些都代表了该计划内扩大和充满活力的优势。49名成员的专业知识涵盖流行病学、分子流行病学、行为科学、传播科学、干预科学、卫生政策和传播。2009年，该方案收到了1 970万美元的癌症相关资金（总费用），其中包括1 190多万美元的国家癌症研究所资金和650万美元的其他联邦同行审查资金。在项目期间（2006年至2010年），该计划成员撰写了903份出版物，其中15.5%为计划内出版物，18%为计划间出版物，16%为计划外出版物，这证明了该计划的生产力和互动性。 机构间合作。

PROJECT SUMMARY (See instructions): The mission of the Cancer Risk and Disparities Program is to support research that will lead to a reduction of cancer risk and disparities across society. To achieve this goal, the Program has the following four specific aims: 1. Understand the individual, psychosocial, organizational and community-level factors that determine differences in cancer risk across the life course and population groups. 2. Develop, test and evaluate interventions to reduce cancer risk across the life course and population groups. 3. Advance the science of communication and knowledge translation to promote dissemination of evidence-based interventions to reduce cancer risk. 4. Examine causes of disparities in cancer risk and incidence and Identify interventions to redress these disparities. The Program was initially funded in 2000 when the Dana-Farber/Harvard Cancer Center was established as a consortium Center, and received a merit score of "excellent to outstanding" at the time of the last renewal in 2005. The Program Is led by L. Frazier(DFCI). There are two Co-Leaders: K. Viswanath (DFCI) and D. Williams(HSPH). During the current project period, the goals of the Program were substantially revised to include new research foci including: 1) the individual and societal factors that predispose to cancer risk, 2) the science of dissemination and 3) an explicit focus on cancer disparities, all of which represent expanded and vibrant strengths within the Program. The expertise of the 49 members spans epidemiology, molecular epidemiology, behavioral science, communication science, intervention science, health policy and dissemination. In 2009, the Program received $19.7 million in cancer-relevant funding (total costs), which included over $11.9 million in NCI funding and $6.5 million in other federal, peer-reviewed funding. Attesting to the productivity and interactivity of the Program are the 903 publications authored by members of the Program during the project period (2006 to 2010), of which 15.5% were Intra-programmatic ,18% were inter-programmatic and 16% were inter-institutional collaborations.